These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35357695)

  • 1. Long-term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update.
    Liu X; Guo K; Lin J; Gong X; Li A; Zhou D; Hong Z
    Epilepsia; 2022 Jul; 63(7):1812-1821. PubMed ID: 35357695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
    Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Symptomatic Seizures and Risk of Seizure Recurrence in Patients with Anti-NMDAR, Anti-LGI1, and Anti-GABA
    Cui D; Feng J; Yang M; Dong Y; Lian Y
    Neurol Sci; 2024 Apr; 45(4):1609-1617. PubMed ID: 37940748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA
    Rada A; Hagemann A; Aaberg Poulsen C; Baumgartner T; Berki T; Blaabjerg M; Brenner J; Britton JW; Christiana A; Ciano-Petersen NL; Crijnen Y; Elišák M; Farina A; Friedman AR; Hayden Z; Hébert J; Holtkamp M; Hong Z; Honnorat J; Ilyas-Feldmann M; Irani SR; Kovac S; Marusic P; Muñiz-Castrillo S; Ramanathan S; Smith KM; Steriade C; Strippel C; Surges R; Titulaer MJ; Uy CE; de Vries JM; Bien CG; Specht U
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200225. PubMed ID: 38838283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
    Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
    J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
    Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
    Front Neurol; 2020; 11():280. PubMed ID: 32431657
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA
    de Bruijn MAAM; van Sonderen A; van Coevorden-Hameete MH; Bastiaansen AEM; Schreurs MWJ; Rouhl RPW; van Donselaar CA; Majoie MHJM; Neuteboom RF; Sillevis Smitt PAE; Thijs RD; Titulaer MJ
    Neurology; 2019 May; 92(19):e2185-e2196. PubMed ID: 30979857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term seizure outcome and antiseizure medication use in autoimmune encephalitis.
    Ilyas-Feldmann M; Prüß H; Holtkamp M
    Seizure; 2021 Mar; 86():138-143. PubMed ID: 33618141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
    Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Seizure and Antiepileptic Drug Utilization in Outpatients With Autoimmune Encephalitis.
    Huang Q; Ma M; Wei X; Liao Y; Qi H; Wu Y; Wu Y
    Front Neurol; 2018; 9():1136. PubMed ID: 30671012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study.
    Liu X; Yan B; Wang R; Li C; Chen C; Zhou D; Hong Z
    Epilepsia; 2017 Dec; 58(12):2104-2111. PubMed ID: 29098690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis.
    Pişkin ŞA; Korkmaz HY; Ulusoy CA; Şanlı E; Küçükali CI; Onat F; Tüzün E; Çarçak N
    Front Immunol; 2023; 14():1268986. PubMed ID: 38035091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure underreporting in LGI1 and CASPR2 antibody encephalitis.
    Baumgartner T; Pitsch J; Olaciregui-Dague K; Hoppe C; Racz A; Rüber T; Becker A; von Wrede R; Surges R
    Epilepsia; 2022 Sep; 63(9):e100-e105. PubMed ID: 35735209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
    Zhang W; Wang X; Shao N; Ma R; Meng H
    Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China.
    Huang T; Liu F; Wang B; Wang C; Hao M; Guo S
    Front Immunol; 2023; 14():1213532. PubMed ID: 38152405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure Characteristics, Outcome, and Risk of Epilepsy in Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
    Qu XP; Vidaurre J; Peng XL; Jiang L; Zhong M; Hu Y
    Pediatr Neurol; 2020 Apr; 105():35-40. PubMed ID: 31917096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
    Kaaden T; Madlener M; Angstwurm K; Bien CG; Bogarin Y; Doppler K; Finke A; Gerner ST; Reimann G; Häusler M; Handreka R; Hellwig K; Kaufmann M; Kellinghaus C; Koertvelyessy P; Kraft A; Lewerenz J; Menge T; Paliantonis A; von Podewils F; Prüss H; Rauer S; Ringelstein M; Rostásy K; Schirotzek I; Schwabe J; Sokolowski P; Suesse M; Sühs KW; Surges R; Tauber SC; Thaler F; Bergh FT; Urbanek C; Wandinger KP; Wildemann B; Mues S; Zettl U; Leypoldt F; Melzer N; Geis C; Malter M; Kunze A;
    Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure Evolution and Outcome in Pediatric Autoimmune Encephalitis.
    Woo H; Shim Y; Chae JH; Kim KJ; Lim BC
    Pediatr Neurol; 2023 Feb; 139():35-42. PubMed ID: 36508881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between autoimmune encephalitis and epilepsy: Systematic review and meta-analysis.
    Chen L; Zhu L; Lu D; Dai S; Han Y; Wu Z; Xu P; Chang L; Wu Q
    Seizure; 2021 Oct; 91():346-359. PubMed ID: 34284303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis.
    Zhong R; Chen Q; Zhang X; Zhang H; Lin W
    Front Immunol; 2022; 13():845365. PubMed ID: 35320933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.